We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome.
- Authors
Kazi, Dhruv S; Garber, Alan M; Shah, Rashmee U; Dudley, R Adams; Mell, Matthew W; Rhee, Ceron; Moshkevich, Solomon; Boothroyd, Derek B; Owens, Douglas K; Hlatky, Mark A
- Abstract
The choice of antiplatelet therapy after acute coronary syndrome (ACS) is complicated: Ticagrelor and prasugrel are novel alternatives to clopidogrel, patients with some genotypes may not respond to clopidogrel, and low-cost generic formulations of clopidogrel are available.
- Publication
Annals of internal medicine, 2014, Vol 160, Issue 4, p221
- ISSN
1539-3704
- Publication type
Journal Article
- DOI
10.7326/M13-1999